Some health-tech devices to watch from the 2025 Consumer Electronics Show.

The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.

ARC-EX is the first FDA-approved technology shown to improve hand strength and sensation patients more than one year post-injury.

HeartBeam plans to initiate an Early Access Program to gather feedback from patients and physicians prior to a commercial launch.

With remote control functionality, Liberty is designed to reduce radiation exposure for physicians and staff and improve ergonomics during procedures.

A new report found that AI in health care settings is primarily used for administrative tasks, with clinical applications still in the early stages of adoption.

With the majority of devices manufactured outside the United States, any increase in tariffs is likely to drive up health care costs, according to a GlobalData analysis.

Through AI technology, Neurophet AQUA now provides multiple sclerosis (MS) analysis with a combination of lesion quantification and enhanced segmentation of T2-FLAIR MRI.

Stone Clear is the first and only device cleared by the FDA that uses external ultrasound pulses to facilitate passage of post-lithotripsy kidney stone fragments without surgery.

The approval is based on results from the admIRE study, which showed 100% of atrial fibrillation patients achieved acute procedural success.

Tarver takes over the lead role at CDRH after serving as interim director since July.

FDA approval of Optune Lua follows the Phase 3 LUNAR trial, showing significant improvement in median overall survival for metastatic NSCLC patients.

As chief medical officer, Foley is expected to guide the clinical direction of True Digital Surgery and the advancement of its Digital Surgical Exoscope Platform.

The app will work alongside prescription drug treatment Flexilev.

The TensWave is designed to provide user-friendly pain relief, complementing Zynex’s NexWave electrotherapy device.

Multiple studies show that an adaptive deep brain stimulation system reduced symptoms associated with Parkinson disease by 50%.

The acquisition of Ypsomed’s pen needles and blood glucose monitoring system is expected to increase MTD’s production capacity to over 2.5 billion units.

Partnership with Abbott for Simplera CGM will expand access to the advanced automated insulin delivery.

Velys recently received 510(k) clearance from the FDA for planning and instrumenting spinal fusion procedures across the cervical, thoracolumbar, and sacroiliac spine.

Ouva’s AI-powered technology will be added to AvaSure’s digital platform.

Clearance of the NeuroLF Brain PET system marks Positrigo’s first device of its kind to be approved in the United States.

Empara’s virtual assistant is the latest attempt to use AI to simplify the user experience in the healthcare industry.

Approval of the Mynx Control Venous vascular closure device was based on results from the ReliaSeal trial, which demonstrated 100% procedural and device success in cardiac ablation procedures.

Cordella is the first pulmonary artery pressure-guided platform indicated for home-based comprehensive heart failure patient management.

The company announced updates to its software to focus on this issue.

Both systems are over-the-counter products that provide continuous glucose monitoring.

According to the manufacturer, the LFR-260 features advanced technology that allows patients to compare multiple prescriptions simultaneously, eliminating the need for traditional refraction methods.

Becton, Dickinson, and Company will acquire Edwards Lifesciences’ Critical Care Product Group for $4.2 billion in cash to expand its own smart connected care solutions.

Roche’s human papillomavirus solution is reportedly one of the first of its kind to be available in the United States.

The catheters approved by the FDA include the Plato 17, a DMSO-compatible microcatheter, and the Socrates 38, an aspiration catheter specifically designed for treating ischemic strokes.